Navigation Links
Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call
Date:11/6/2009

PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its third quarter 2009 results before market on Monday, November 16, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call (866) 788-0546 (domestic) or (857) 350-1684 (international), with passcode 81416481 to access the call. You may also access this call via the Internet at:

http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=2539678

For those who are unavailable to listen to the live broadcast, a replay will be available through December 16, 2009 and can be accessed by dialing 888-286-8010 (domestic), and 617-801-6888 (international). The passcode is 43541503.

About Derma Sciences

Derma Sciences is a specialty medical device / pharmaceutical company focusing on advanced wound care. Its key product, MEDIHONEY®, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was the focus of a positive large-scale randomized controlled trial on leg ulcers. Derma's recently FDA cleared BIOGUARD(TM) Barrier Dressing is the Company's latest new product entrant into the $14 billion global wound care market. The barrier technology was licensed from Quick-Med Technologies, Inc. in Q1 of 2007. Derma also has in development DSC127, a novel angiotensin analog for accelerated wound healing and scar reduction. DSC127 was licensed from the University of Southern California in Q4 of 2007. Patient enrollment for a Phase II study began in Q4 of 2008. Resu
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R)
2. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
3. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
4. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
5. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
6. BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
7. Clinical Trial Results of Pollogens TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology
8. Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study
9. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...N LAKES, N.J., Nov. 20 B...oday announced the completion of its acquisition o...pany that develops and manufactures molecular diag...ay 2009, BD and HandyLab announced an exclusive ag...lar assays on the HandyLab Jaguar(TM) platform, th...
(Date:11/19/2009)...NGHAM, Ala., Nov. 19 Bio... announced the pricing of a public offering of 5,0...re, resulting in gross proceeds of $48.75 million....pursuant to an effective shelf registration statem...nge Commission. BioCryst has also granted the und...
(Date:11/19/2009)...N VIEW, Calif., Nov. 19 ...unced today that its corporate presentation will b...y Health Care Conference on Wednesday, December 2,... will be webcast from The New York Palace Hotel in... Alexza President and CEO. ,, To access the l...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cancer Survivors Share The Day I Found Out 28TM 29 58807 1Cancer Survivors Share The Day I Found Out 28TM 29 58807 2Brookdale to Present at JMP Securities Healthcare Focus Conference 58804 1Pharmatek Laboratories Announces Acquisition of the First Xcelodose 28R 29 600S System on the West Coast 5201 1Pharmatek Laboratories Announces Acquisition of the First Xcelodose 28R 29 600S System on the West Coast 5201 2
...)--Mar 19, 2007 - ACADIA Pharmaceuticals,Inc. (Nas...s from,its Phase II schizophrenia co-therapy trial...5-HT2A inverse agonist. The trial,evaluated ACP-10...idone, a commonly prescribed atypical antipsychoti...hotic drug. The co-therapy,arms with ACP-103 demon...
...2007 - The antidepressant duloxetine, at,a once-da...fic pain,and emotional symptoms associated with de...study of 327 adult patients with at,least moderate...nted today at the 15th European Congress of Psychi...r of a class of drugs commonly referred to as,sero...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 2In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 3In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 4In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 5In New Study, Duloxetine Reduced Non-specific Pain and Emotional,Symptoms Associated with Depression 6
(Date:11/20/2009)... , HINESBURG, Vt., Nov. 20 Kes...any that specializes in creating sophisticated med... announced the launch www.infectioncontrolsource....re administrators with a comprehensive database of... "Our mission at Kestrel is to educate healthcare ...
(Date:11/20/2009)... , LOS ANGELES, Nov. 20 As w... feasts, more than 1.25 million people in Los Ange...tand the magnitude of the problem, that,s nearly t...people you see every day are hungry - and the situ...ntinues to increase. ,, The Jewish Federation ...
(Date:11/20/2009)...molecule identified by researchers , , ...y be moving closer to better treatments for bovine...w disease, and the related condition called Creutz...n-1 is crucial to the development of mad cow disea...standing its role could help scientists figure out...
(Date:11/20/2009)...ng menstrual cycle into account when booking exam ... , FRIDAY, Nov. 20 (HealthDay News) -- Usin...reast MRI scans in women with irregular menstrual .... researchers say. , Previous studies have foun...icular phase (days 3 to14) of the menstrual cycle ...
(Date:11/20/2009)...simple blood test corresponding to the follicular ...aid in optimal scheduling of breast MRI exams in p... reducing the number of repeat scans and non-diagn...rer images on which doctors make their recommendat...er issue of the American Journal of Roentgenology...
Breaking Medicine News(10 mins):Health News:Infection Prevention Online Community Site Launches - Focused on Product Selection 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 3Health News:Blood Test Could Boost Clarity of Breast MRI Results for Some 2
...ELLE, N.Y., Jan. 8 Natural gas, believed to be am...e airborne particulate matter when burned in home ...ccording to a report in the December 2008 issue (V...lable free online at www.liebertpub.com/ees , ,...
...Olympics Minnesota receives $20,000 to support loc...cs initiative , , MINNEAPOLIS, Minn., Jan. 8 S...0 in funding to support Project UNIFY as part of S... promote school communities where all young people...
...Employee Union Confident Daschle Will Seek Expande... The American Federation of Government Employees (..., congratulates former Senate Majority Leader Tom ...sident Obama,s selection of Daschle proves he is c...
...sts have tricked bone marrow into releasing extra ... that they hope could one day be used to repair he...ublished today in the journal Cell Stem Cell . ,...arch, by researchers from Imperial College London,...
...inical study found a new nasal spray vaccine to pr... toxin, according to a study published today in th...used by a bacterium, Clostridium botulinum , whic...percent are infant botulism (infants, intestines, ...
...safety advocates to launch congressional campaign ...ts solutions to reduce annual 40,000 deaths and $2...t of ,2009 Roadmap to State Highway Safety Laws, N...cross the nation gear up for their 2009 sessions, ...
Other Medicine News:Health News:Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal 2Health News:Special Olympics Minnesota Launches Project UNIFY to Energize Youth 2Health News:Scientists call up stem cell troops to repair the body using new drug combinations 2Health News:Scientists call up stem cell troops to repair the body using new drug combinations 3Health News:Nose-spray vaccine against botulism effective in first tests 2Health News:Nose-spray vaccine against botulism effective in first tests 3Health News:Nose-spray vaccine against botulism effective in first tests 4Health News:Each State to Receive Report Card Grading Their Progress in Passing Model Traffic Safety Laws 2
IEC CL30 Centrifuge
Automatic Blood Pressure Monitor
FreeStyle Freedom Blood Glucose Monitoring System
REAL-Time Continuous Glucose Monitoring
Medicine Products: